BORTEZOMIB and PYREXIA

Overview

PYREXIA is the #11 most commonly reported adverse reaction for BORTEZOMIB, manufactured by Takeda Pharmaceuticals America, Inc.. There are 2,799 FDA adverse event reports linking BORTEZOMIB to PYREXIA. This represents approximately 2.0% of all 141,037 adverse event reports for this drug.

Patients taking BORTEZOMIB who experience pyrexia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

PYREXIA is a less commonly reported adverse event for BORTEZOMIB, but still significant enough to appear in the safety profile.

Other Side Effects of BORTEZOMIB

In addition to pyrexia, the following adverse reactions have been reported for BORTEZOMIB:

• PLASMA CELL MYELOMA — 8,874 reports
• NEUROPATHY PERIPHERAL — 6,256 reports
• OFF LABEL USE — 6,143 reports
• DIARRHOEA — 5,060 reports
• FATIGUE — 4,443 reports
• DEATH — 4,100 reports
• PNEUMONIA — 3,968 reports
• DRUG INEFFECTIVE — 3,584 reports
• THROMBOCYTOPENIA — 3,577 reports
• NAUSEA — 3,044 reports

Other Drugs Associated with PYREXIA

The following drugs have also been linked to pyrexia in FDA adverse event reports:

Does BORTEZOMIB cause PYREXIA?

PYREXIA has been reported as an adverse event in 2,799 FDA reports for BORTEZOMIB. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is PYREXIA with BORTEZOMIB?

PYREXIA accounts for approximately 2.0% of all adverse event reports for BORTEZOMIB, making it a notable side effect.

What should I do if I experience PYREXIA while taking BORTEZOMIB?

If you experience pyrexia while taking BORTEZOMIB, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages